Summit Therapeutics logo

Summit Therapeutics

Brand · Biotechnology Research

Company overview

Summit Mission Statement:To build a viable, long-lasting health care organization that assumes full responsibility for designing, developing, trial execution and enrollment, regulatory submission and approval, as well as successful commercialization of patient, physician, caregiver, and societal-friendly medicinal therapy intended to: improve quality of life, increase potential duration of life, and resolve serious medical healthcare needs. To identify and control promising product candidates based on exceptional scientific development and administrational expertise, develop our products in a rapid, cost-efficient manner, and to engage commercialization and/or development partners when appropriate.We accomplish this by building a team of world class professional scientists and business administrators that apply their experience and knowledge to this mission. Team Summit exists to pose, strategize, and execute a path forward in medicinal therapeutic health care that places Summit in a well-deserved, top market share, leadership position. Team Summit assumes full responsibility for stimulating continuous expansion of knowledge, ability, capability, and well-being for all involved stakeholders and highly-valued shareholders.Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Miami, Florida, and we have additional offices in Menlo Park, California, and Oxford, UK.
Founded in 2003
Miami, Florida, USA
321 employees

Salaries

Typical salary range

$190,000 – $230,000

/ yr

Help build salary transparency at Summit Therapeutics

Share your compensation anonymously to see full data.

Contribute

People

Marketing leadership

Hiring activity

Open marketing jobs over time

7 open now

Headcount trend

Company growth over the last 12 months

Headcount +49.8% year over year

Funding

Total funding

$1.8B

Last raise

$500M

Post IPO Equity, 5 months ago

Funding history

Oct 2025

Post IPO Equity Summit Therapeutics · $500M

Sep 2024

Post IPO Equity Summit Therapeutics · $235M

Jun 2024

Post IPO Equity Summit Therapeutics · $200M

Jan 2023

Post IPO Equity Summit Therapeutics · $500M

Jul 2022

Post IPO Equity Summit Therapeutics · $100M

May 2021

Grant Summit Therapeutics · $4.1M

Audience

Monthly website visitors
34.1K
Month over month+25.1%
Quarter over quarter+38.3%
Top sourceSearch (50.3%)
Ad budget per month$0.0
Average search rank51
Traffic source mix
Search
50.3%
Direct
40.7%
Referral
6.3%
Social
1.6%
Paid referral
1.1%

LinkedIn followers

Follower count and growth

Total followers

54.7K

12-mo growth

+87.6%

Monthly growth

+6.6%

News

Links